Skip to content
Becton, Dickinson and Company (BD)
-
BD partners with Ypsomed to develop 5.5 ml syringe for high-dose biologics
The newly developed syringe has been specifically engineered to work seamlessly with Ypsomed’s YpsoMate 5.5 autoinjector platform.
-
BD invests USD110M to boost US syringe production for biologics
The company plans to bring Neopak Glass Prefillable Syringe production to its long-established facility in Columbus, Nebraska.
-
BD introduces Surgiphor surgical wound irrigation system in Europe to improve surgical care
Surgiphor is formulated as a pre-mixed, sterile irrigation solution designed to help clear surgical wounds of debris and foreign materials during procedures, eliminating the need for hospital staff to prepare the solution on-site.